Xavier Matias-Guiu Guia
Degree: PhD
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Groups
Publications
-
Matias-Guiu, X; Selinger, CI; Anderson, L; Buza, N; Ellenson, LH; Fadare, O; Ganesan, R; Ip PPC; Palacios, J; Parra-Herran, C; Raspollini, MR; Soslow, RA; Werner HMJ; Lax, SF; McCluggage, WG
Data Set for the Reporting of Endometrial Cancer: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 41 90-118. .
-
Barcelo, C.; Siso, P.; de la Rosa, I.; Megino-Luque, C.; Navaridas, R.; Maiques, O.; Urdanibia, I.; Eritja, N.; Soria, X.; Potrony, M.; Calbet-Llopart, N.; Puig, S.; Matias-Guiu, X.; Marti, R. M.; Macia, A.
M-CSF as a therapeutic target in BRAF(V600E) melanoma resistant to BRAF inhibitors.
BRITISH JOURNAL OF CANCER 127 1142-1152. .
-
Egan D; Moran B; Wilkinson M; Pinyol M; Guerra E; Gatius S; Matias-Guiu X; Kolch W; le Roux CW; Brennan DJ
CRABP2 - A novel biomarker for high-risk endometrial cancer.
GYNECOLOGIC ONCOLOGY 167 314-322. .
-
Vrede SW; Hulsman AMC; Reijnen C; Van de Vijver K; Colas E; Mancebo G; Moiola CP; Gil-Moreno A; Huvila J; Koskas M; Weinberger V; Minar L; Jandakova E; Santacana M; Matias-Guiu X; Amant F; Snijders MPLM; Küsters-Vandevelde HVN; Bulten J; Pijnenborg JMA
The amount of preoperative endometrial tissue surface in relation to final endometrial cancer classification.
GYNECOLOGIC ONCOLOGY 167 196-204. .
-
Carretero-Barrio I; Lop-Gros J; Iglesias M; Martínez C; Matias-Guiu X; Pérez-Mies B; Palacios J
Impact of the COVID-19 pandemic on pathology training: a survey among Spanish residents.
VIRCHOWS ARCHIV 481 1-5. .
-
Ruiz-Mitjana, A; Navaridas, R; Vidal-Sabanes, M; Perramon-Guell, A; Yeramian, A; Felip, I; Eritja, N; Egea, J; Encinas, M; Matias-Guiu, X; Dolcet, X
Lack of extracellular matrix switches TGF-ß induced apoptosis of endometrial cells to epithelial to mesenchymal transition.
SCIENTIFIC REPORTS 12 14821-14821. .
-
Gatius S; Jove M; Megino-Luque C; Albertí-Valls M; Yeramian A; Bonifaci N; Piñol M; Santacana M; Pradas I; Llobet-Navas D; Pamplona R; Matías-Guiu X; Eritja N
Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer.
Cancers 14 -. .
-
Megino-Luque, Cristina; Siso, Pol; Mota-Martorell, Natalia; Navaridas, Raul; de la Rosa I; Urdanibia, Izaskun; Alberti-Valls, Manel; Santacana, Maria; Pinyol, Miquel; Bonifaci, Nuria; Macia, Anna; Llobet-Navas, David; Gatius, Sonia; Matias-Guiu, Xavier; Eritja, Nuria
ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.
MOLECULAR ONCOLOGY 16 2235-2259. .
-
Jiménez-Sánchez D; Ariz M; Chang H; Matias-Guiu X; de Andrea CE; Ortiz-de-Solórzano C
NaroNet: Discovery of tumor microenvironment elements from highly multiplexed images.
MEDICAL IMAGE ANALYSIS 78 102384-102384. .
-
Gatius, S; Velasco, A; Varela, M; Cuatrecasas, M; Jares, P; Setaffy, L; Bonhomme, B; Santon, A; Lindemann, K; Croce, S; Davidson, B; Lax, S; Palacios, J; Matias-Guiu, X
Comparison of the Idylla™ MSI assay with the Promega™ MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter study.
VIRCHOWS ARCHIV 480 1031-1039. .
-
Garcia-Garcia, Mar; Alvarez Alegret, Ramiro; Perez-Mies, Belen; Iglesias, Mar; Ramon Y Cajal, Santiago; Matias-Guiu, Xavier; Rodriguez Peralto, Jose Luis
La necesidad de la coordinación técnica en los servicios de Anatomía Patológica. Documento de posicionamiento de la Sociedad Española de Anatomía Patológica.
REVISTA ESPANOLA DE PATOLOGIA 55 122-124. .
-
Temprana-Salvador J; López-García P; Castellví Vives J; de Haro L; Ballesta E; Rojas Abusleme M; Arrufat M; Marques F; Casas JR; Gallego C; Pons L; Mate JL; Fernández PL; López-Bonet E; Bosch R; Martínez S; Ramón Y Cajal S; Matias-Guiu X
DigiPatICS: Digital Pathology Transformation of the Catalan Health Institute Network of 8 Hospitals-Planification, Implementation, and Preliminary Results.
Diagnostics 12 -. .
Projects
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
- Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment
